Polaris Logo - v2.png
Global Laboratory Developed Tests Market Worth USD 22.30 Billion, Growing at a 6.9% CAGR from 2024 to 2032 - Report by Polaris Market Research (PMR)
May 22, 2024 09:10 ET | Polaris Market Research & Consulting LLP
New York, May 22, 2024 (GLOBE NEWSWIRE) -- Market Overview: The Global Laboratory Developed Tests Market was valued at USD 12.21 billion in 2023 and is anticipated to generate an estimated revenue...
visiongain Logo.png
Clinical Laboratory Tests Market Worth US$421.06 billion by 2031: Visiongain Research Inc.
June 14, 2021 09:00 ET | Visiongain Ltd
Visiongain has published a new report on “Clinical Laboratory Tests Market Report Forecast 2021-2031”. Forecasts by Type (Basic Metabolic Panel Tests, Complete Blood Count, HGB/HCT Tests, Electrolytes...
admera_health_final_logo_transparent_final.jpg
Chinese-Based MedCDx and US-Based Admera Health Enter Into Strategic Partnership to Co-Develop Companion Diagnostics
February 26, 2019 09:21 ET | Admera Health, LLC
SOUTH PLAINFIELD, N.J., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Today, MedCDx and Admera Health announced a non-exclusive collaborative agreement. Under the terms of the agreement, MedCDx (formerly Qiagen...
DNA
Calling Clients on Duplicate Testing Saves Them Money
August 25, 2015 09:14 ET | ARUP Laboratories
SALT LAKE CITY, Aug. 25, 2015 (GLOBE NEWSWIRE) -- The red flag was waved last spring, when Cindy Meadows, an ARUP Laboratory group manager in genetics, was reviewing client reports and realized that...